Department of Immunobiology, University of Lausanne, 155 Ch. des Boveresses, 1066 Epalinges, Switzerland.
Department of Immunobiology, University of Lausanne, 155 Ch. des Boveresses, 1066 Epalinges, Switzerland.
Cell Rep. 2022 Nov 15;41(7):111636. doi: 10.1016/j.celrep.2022.111636.
The PYRIN inflammasome pathway is part of the innate immune response against invading pathogens. Unprovoked continuous activation of the PYRIN inflammasome drives autoinflammation and underlies several autoinflammatory diseases, including familial Mediterranean fever (FMF) syndrome. PYRIN inflammasome formation requires PYRIN dephosphorylation and oligomerization by molecular mechanisms that are poorly understood. Here, we use a functional genetics approach to find regulators of PYRIN inflammasome function. We identify the small Rho GTPase CDC42 to be essential for PYRIN activity and oligomerization of the inflammasome complex. While CDC42 catalytic activity enhances PYRIN phosphorylation, thereby inhibiting it, the inflammasome-supportive role of CDC42 is independent of its GDP/GTP binding or hydrolysis capacity and does not affect PYRIN dephosphorylation. These findings identify the dual role of CDC42 as a regulator of PYRIN and as a critical player required for PYRIN inflammasome assembly in health and disease.
PYRIN 炎症小体途径是先天免疫系统对抗入侵病原体的一部分。PYRIN 炎症小体的无端持续激活会导致自身炎症,并构成几种自身炎症性疾病的基础,包括家族性地中海热 (FMF) 综合征。PYRIN 炎症小体的形成需要 PYRIN 通过分子机制去磷酸化和寡聚化,但这些机制还不太清楚。在这里,我们使用功能遗传学方法来寻找 PYRIN 炎症小体功能的调节剂。我们发现小 Rho GTPase CDC42 对 PYRIN 活性和炎症小体复合物的寡聚化至关重要。虽然 CDC42 的催化活性增强了 PYRIN 的磷酸化,从而抑制了它,但 CDC42 对炎症小体的支持作用不依赖于其 GDP/GTP 结合或水解能力,也不影响 PYRIN 的去磷酸化。这些发现确定了 CDC42 的双重作用,既是 PYRIN 的调节剂,也是 PYRIN 炎症小体在健康和疾病中组装所必需的关键参与者。